510(k) device
EndoflipTM 300 System
Covidien, LLC · System, Gastrointestinal Motility (Electrical) (FFX, Class II) · First FDA decision Apr 14, 2023, newest Jul 21, 2023Fecal incontinence and constipation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "EndoflipTM 300"
MAUDE reports
0
Brand "EndoflipTM 300", since 2015
PubMed studies
0
Mentioning "EndoflipTM 300"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EndoflipTM 300 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- EndoflipTM 300 System510(k)
K231861 · Decided Jul 21, 2023 · 28 days after receipt
Device type: System, Gastrointestinal Motility (Electrical) (FFX) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wireless Gastrointestinal Motility Monitoring SystemsLocal determinationIn effectL33455Palmetto GBAUpdated Sep 3, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "EndoflipTM 300", any status and sponsor, newest update first.
No registered device study names "EndoflipTM 300".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EndoflipTM 300", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FFX
397 reports: 326 malfunction, 69 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EndoflipTM 300"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FFX.
- EndoFLIP SystemCrospon, Ltd. · 510(k) 2019
- Solar GiMedical Measurement Systems B.V. · 510(k) 2012
- Rapid Barostat Bag (RBB) Pump and Catheter SystemMui Scientific, Inc. · 510(k) 2026
- Transit-PelletsMedifactia AB · 510(k) 2023
- Polygram 98 Anorectal Function Testing ApplicationMedtronic Functional Diagnostics A/S · 510(k) 2001
- mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001)Medspira, LLC · 510(k) 2025
- Solar Compact (G4-1)Laborie Medical Technologies, Corp. · 510(k) 2024
- IntraMarX 3D Radiopaque MarkerAnx Robotica Corp · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.